Quote:
Originally Posted by jfman
I don’t really see how that can be true. It’s not an absolute ban it’s simply moving as emerging data improves. If we are truly interested in the “entire planet” we should remove the IP rights on all vaccines and get production ramped up. Otherwise a time delay on subset of the population in France is likely to have negligible impact on the global response or inevitable emergence of vaccine resistant mutations.
However some good news that should finally end the uncertainty is the outcome of the Phase 3 US clinical trials showing 79% efficacy. While not one to necessarily trust the BBC quick fire analysis the published data should let more independent sources crunch the numbers.
|
Where is your evidence that a block on IP rights is being imposed and is causing delays? For the AZ vaccine, the only requirement that might be a sticking point, is that it has to be supplied at cost.
The EU is threatening to hijack IP rights, but then what? They would still need to build and set up any manufacturing sites, and that takes time. Are they planning to produce AZ vaccine for a profit?